Literature DB >> 35596071

CMS coverage decision on anti-amyloid monoclonal antibodies for Alzheimer disease.

David Knopman1, Mary Sano2, Howard H Feldman3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35596071     DOI： 10.1038/s41582-022-00672-3

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   44.711


× No keyword cloud information.
  2 in total

1.  Assessing the Preparedness of the Health Care System Infrastructure in Six European Countries for an Alzheimer's Treatment.

Authors:  Jakub P Hlavka; Soeren Mattke; Jodi L Liu
Journal:  Rand Health Q       Date:  2019-05-16

2.  Aducanumab: Appropriate Use Recommendations.

Authors:  J Cummings; P Aisen; L G Apostolova; A Atri; S Salloway; M Weiner
Journal:  J Prev Alzheimers Dis       Date:  2021
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.